Cascade Bancorp (CACB) Drops 5.53% on January 15

Equities Staff |

Cascade Bancorp (CACB) was one of the Russell 2000's biggest losers for Friday January 15 as the stock slid 5.53% to $5.30, a loss of $-0.31 per share. Starting at an opening price of $5.45 a share, the stock traded between $5.20 and $5.49 over the course of the trading day. Volume was 77,398 shares over 540 trades, against an average daily volume of 82,320 shares and a total float of 72.78 million.

The losses send Cascade Bancorp down to a market cap of $385.73 million. In the last year, Cascade Bancorp has traded between $6.25 and $4.14, and its 50-day SMA is currently $5.92 and 200-day SMA is $5.39.

The stock has a P/E Ratio of 19.3.

Cascade Bancorp is a bank holding company. The Company through its wholly-owned subsidiary, Bank of the Cascades, offers commercial and retail banking services to its customers.

Cascade Bancorp is based out of Bend, OR and has some 513 employees. Its CEO is Terry E. Zink.

For a complete fundamental analysis analysis of Cascade Bancorp, check out Equities.com’s Stock Valuation Analysis report for CACB. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Taranis Resources Inc.

Taranis Resources Inc is an exploration stage company. The Company along with its subsidiaries is engaged in the acquisition and exploration of mineral properties. Its projects include Thor Property in…

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…